In this podcast episode, David Anderson from Ampersand Capital Partners discusses the firm's journey from focusing on materials to becoming a leader in healthcare investments. He emphasizes their commitment to integrating scientific insight into their investment strategies. David shares his thoughts on their hands-on approach with portfolio companies like Brammer Bio, and highlights Ampersand's dedication to advanced therapies and collaboration. He also touches on the significance of philanthropy and company culture in driving success at Ampersand, underscoring how building meaningful partnerships helps tackle pressing health challenges.
